Advisor Group Holdings, Inc. Forte Biosciences, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$1.06 - $27.75 $530 - $13,875	500 Added 86.21%	1,080 $2,000
Q2 2022 Aug 10, 2022	SELL	$1.07 - $1.55 $258 - $375	-242 Reduced 29.44%	580 $1,000
Q1 2022 May 04, 2022	BUY	$1.21 - $2.24 $837 - $1,550	692 Added 532.31%	822 $1,000
Q3 2021 Nov 05, 2021	SELL	$2.96 - $36.67 $988 - $12,247	-334 Reduced 71.98%	130 $0
Q2 2021 Aug 02, 2021	BUY	$31.5 - $42.5 $7,339 - $9,902	233 Added 100.87%	464 $15,000
Q1 2021 May 13, 2021	BUY	$25.01 - $40.24 $2,000 - $3,219	80 Added 52.98%	231 $8,000
Q4 2020 Feb 10, 2021	BUY	$28.66 - $46.79 $1,031 - $1,684	36 Added 31.3%	151 $6,000
Q3 2020 Nov 12, 2020	BUY	$14.71 - $50.69 $1,603 - $5,525	109 Added 1816.67%	115 $6,000
Q2 2020 Aug 14, 2020	BUY	$13.9 - $24.6 $83 - $147	6 New	6 $0

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.